A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan
City of Hope Medical Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
University of Alabama at Birmingham
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
National Cancer Institute (NCI)